StockVS

Cellebrite DI Ltd. (CLBT) Stock Analysis

Technology

Cellebrite DI Ltd.

$12.89

$-0.29 (-2.20%)

Last Updated: May 26, 2026

Price History

Analysis

Company Overview

Cellebrite DI Ltd. operates by developing specialized software and services designed for legally sanctioned investigations across Europe, the Middle East, Africa, the Americas, and the Asia-Pacific regions. The company functions within the Technology sector, specifically focusing on the Software - Infrastructure industry, which implies a reliance on proprietary intellectual property and scalable digital solutions rather than physical manufacturing. This entity is a significant market participant with a market capitalization of $3.70B, generating annual revenue of $475.68M and employing a workforce of 1285 individuals. These valuation and revenue figures indicate that the market assigns a substantial premium to the company's infrastructure capabilities, suggesting strong investor confidence in its recurring revenue model and the critical demand for its investigative tools.

Financial Health

The company reported revenue of $475.68M over the trailing twelve months, resulting in a net income of $77.81M and an EBITDA of $78.35M. The gap between the revenue figure and the net income reveals a cost structure where operating expenses, likely dominated by research and development and sales costs, consume approximately 83.5% of total revenue before interest and taxes are considered. Free cash flow stands at $140.94M, which signifies a robust generation of cash relative to capital expenditures, providing the company with significant financial flexibility for strategic investments or balance sheet optimization. Profitability metrics demonstrate a gross margin of 84.2%, an operating margin of 16.1%, and a profit margin of 16.5%, indicating highly efficient production and pricing power alongside effective control over overhead costs. The balance sheet presents a conservative profile with total cash holdings of $437.05M compared to total debt of $22.67M, supported by a debt-to-equity ratio of 4.68 which reflects a very low leverage position despite the high ratio name often implying risk, as the numerator here is cash and the denominator is equity, but strictly speaking, the absolute debt load is minimal relative to cash. Short-term liquidity is strong with a current ratio of 1.56, indicating the company holds sufficient current assets to cover its short-term liabilities without immediate distress. Management effectiveness is highlighted by a return on equity of 19.1% and a return on assets of 5.1%, demonstrating that the company generates high returns on the capital shareholders have invested while utilizing its asset base efficiently to produce earnings.

Valuation Assessment

Valuation multiples show a trailing P/E ratio of 47.87 against a forward P/E of 24.33, implying that the market expects earnings growth that will eventually bring the valuation multiple down to the forward level or that current earnings are depressed relative to future expectations. The price-to-book ratio is 7.62, indicating that the market values the company at a significant premium over its net asset book value, reflecting the high intangible value of its software portfolio. Alternative valuation metrics such as a price-to-sales ratio of 7.78 and an EV/EBITDA of 41.96 suggest that investors are pricing the stock based on future growth potential and profitability rather than current asset backing. Price action over the last year has ranged between a 52-week low of $11.76 and a 52-week high of $20.86, placing the stock's current trajectory within a historical context of significant volatility. The beta value of 1.33 indicates that the stock is more volatile than the broader market, meaning price movements are amplified relative to general market shifts.

Growth & Income

Revenue growth is currently at 18.1% year-over-year, while earnings growth is at 1.8% year-over-year, revealing that earnings are growing significantly slower than revenue, which implies that cost of goods sold, operating expenses, or one-time charges are absorbing the benefits of top-line expansion. The company does not pay dividends, evidenced by a dividend yield of N/A and a payout ratio of 0.0%, which means the company reinvests all of its earnings into growth initiatives, technology development, and operational expansion rather than returning capital to shareholders. This non-dividend profile aligns with the high growth revenue figures, prioritizing capital allocation for future market share gains over immediate income generation for investors. The overall growth and income profile is characterized by aggressive revenue expansion funded by strong cash flows, with no current reliance on dividend income to support shareholder returns.

Peer Comparison

Cellebrite DI Ltd. (CLBT) operates in the Software - Infrastructure industry. Here is how it compares to its closest peers by market capitalization:

Company Ticker Market Cap P/E Ratio
Cellebrite DI Ltd. CLBT $3.22B 46.0
Microsoft Corporation MSFT.TO $4.10T 24.0
Microsoft Corporation MSFT $3.11T 24.9
Oracle Corporation ORCL $552.43B 34.5

The Software - Infrastructure industry average P/E ratio is 60.1x. Cellebrite DI Ltd. trades at a P/E of 46.0.

This analysis is AI-generated for informational purposes only and should not be considered financial advice. Data may be delayed or inaccurate. Always do your own research and consult a qualified financial advisor before making investment decisions.

About Cellebrite DI Ltd.

Cellebrite DI Ltd. develops software and services for legally sanctioned investigations in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. The company provides a platform of software solutions used to access, collect, review, extract, decode, decrypt, analyze, share and manage digital evidence across the investigative lifecycle for a range of investigations, such as child exploitation, homicide, anti-terror, border control, sexual crimes, organized crime, human trafficking, corporate security, and intellectual property theft, as well as financial crimes, including those involving cryptocurrency. It also offers Inseyets, digital forensics software that collects and reviews digital evidence from various digital sources when conducting legally sanctioned investigations; Guardian Forensics, an evidence management solution which enables customers to manage their digital forensics workflows, and to store, share and review digital evidence; Guardian Collaborate, a digital evidence sharing tool; and Guardian Investigate, a case management and AI-powered analytics solution. In addition, it provides Cellebrite Pathfinder, which reduces the time spent manually reviewing digital evidence and enables actionable insights into a range of crime types; Corellium Falcon for conducting mobile vulnerability research, exploit introspection, and malware analysis; and Corellium Viper for mobile application penetration testing capabilities. Further, the company offers professional services, such as training and certification services, and advanced services. It serves federal, state, and local agencies, as well as corporations and service providers. The company is headquartered in Petah Tikva, Israel.

Visit website →

Key Statistics

Market Cap
$3.22B
P/E Ratio
46.04
52-Week High
$19.98
52-Week Low
$11.02
Avg Volume
1.92M
Beta
1.15

Data provided by Yahoo Finance via yfinance. Updated daily.

Company Info

Exchange
NASDAQ
Country
Israel
Employees
1,285